# “Assessment of diabetes management strategies for blood glucose control in Sana’a City General Hospitals”

**Authors:** Ali Salman Al-Shami, Mokhtar Alzumor, Adnan Aladhal, Yaser Al-Worafi, Zaid A. Thawaba

PMC · DOI: 10.3389/fendo.2025.1587901 · Frontiers in Endocrinology · 2025-07-17

## TL;DR

This study evaluates diabetes management in Yemeni hospitals, finding that treatment adherence and lifestyle changes improve blood glucose control and reduce complications.

## Contribution

The study provides insights into diabetes management strategies in Sana’a City hospitals and identifies factors associated with better glucose control.

## Key findings

- Type 2 Diabetes Mellitus was more prevalent than insulin-dependent diabetes mellitus (80% vs. 20%).
- Patients adhering to treatment, exercise, and nutrition showed better clinical and biochemical profiles.
- Laboratory monitoring was the most common management strategy, while lifestyle adherence was lower.

## Abstract

Diabetes mellitus is a major global health concern associated with serious complications. Effective management of blood glucose levels is crucial in reducing these complications.

This study aimed to evaluate blood glucose management strategies among diabetic patients in general hospitals in Sana’a city, Yemen.

A cross-sectional study was conducted involving 50 diabetic patients. Data on demographics, risk factors, treatment adherence, lifestyle habits, and biochemical markers were collected through questionnaires and laboratory tests. Statistical analysis was performed using SPSS.

The study found a higher prevalence of diabetes among males, individuals aged 41–60 years, married persons, and those who were illiterate. “Type 2 Diabetes Mellitus was more common than insulin-dependent diabetes mellitus (IDDM) (80% vs. 20%). Laboratory monitoring was the most commonly used management strategy, while adherence to treatment, exercise, and nutrition was lower. Patients adhering to treatment, exercise, and nutrition therapy showed significantly better clinical and biochemical profiles, including lower LDL, triglycerides, total cholesterol, HbA1c, fasting blood sugar, BMI, and blood pressure levels. The prevalence of diabetes complications was lower among patients who followed management protocols.

Regular treatment adherence, exercise, nutrition therapy, and laboratory monitoring contribute to improved blood glucose control and reduce diabetes-related complications. Enhancing patient education and adherence to management strategies is essential for better clinical outcomes.

## Linked entities

- **Diseases:** Diabetes mellitus (MONDO:0005015), Type 2 Diabetes Mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}
- **Diseases:** hypertension (MESH:D006973), hyperthyroidism (MESH:D006980), IDDM (MESH:D003922), nerve damage (MESH:D000080902), proteinuria (MESH:D011507), diabetic nephropathy (MESH:D003928), Cushing's syndrome (MESH:D003480), glucagonoma (MESH:D005935), ketosis (MESH:D007662), diabetes complications (MESH:D048909), obesity (MESH:D009765), blindness (MESH:D001766), heart attack (MESH:D009203), weight loss (MESH:D015431), foot gangrene (MESH:D005734), infections (MESH:D007239), glycosuria (MESH:D006029), metabolic disease (MESH:D008659), renal failure (MESH:D051437), Non-insulin-dependent diabetes mellitus (MESH:D003924), hyperosmolar coma (MESH:D006944), eye disorders (MESH:D005128), fibrosis (MESH:D005355), glomerular sclerosis (MESH:D007674), neuropathy (MESH:D009422), retinopathy (MESH:D058437), hypoglycaemia unawareness (MESH:D018458), pancreatitis (MESH:D010195), microvascular complications (OMIM:603933), heart-related (MESH:D006331), relative insulin deficiency (MESH:D000080822), insulin resistance (MESH:D007333), DM (MESH:D003920)
- **Chemicals:** blood glucose (MESH:D001786), prednisone (MESH:D011241), lipid (MESH:D008055), TG (MESH:D014280), creatinine (MESH:D003404), ketone bodies (MESH:D007657), sugar (MESH:D000073893), cholesterol (MESH:D002784), glucose (MESH:D005947)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310487/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310487/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310487/full.md

---
Source: https://tomesphere.com/paper/PMC12310487